"Overall lung cancer" trang 1 - tải miễn phí từ tailieuXANH
Genetic polymorphism rs3760396 of the chemokine (C-C motif) ligand 2 gene (CCL2) associated with the susceptibility of lung cancer in a pathological subtype-specific manner in Han-ancestry Chinese: A case control study

Genetic polymorphism rs3760396 of the chemokine (C-C motif) ligand 2 gene (CCL2) associated with the susceptibility of lung cancer in a pathological subtype-specific manner in Han-ancestry Chinese: A case control study
7    78    0
The association of aspirin use with overall survival of patients with inoperable non-small cell lung cancer: A retrospective study

The association of aspirin use with overall survival of patients with inoperable non-small cell lung cancer: A retrospective study
10    260    1
NKX2–1 expression as a prognostic marker in early-stage non-small-cell lung cancer

NKX2–1 expression as a prognostic marker in early-stage non-small-cell lung cancer
9    52    1
Comparative analysis of overall survival in non-small cell lung cancer patients with and without different organ metastases

Comparative analysis of overall survival in non-small cell lung cancer patients with and without different organ metastases
6    6    1
Clinicopathological variables influencing overall survival, recurrence and postrecurrence survival in resected stage I nonsmall-cell lung cancer

Clinicopathological variables influencing overall survival, recurrence and postrecurrence survival in resected stage I nonsmall-cell lung cancer
10    62    0
Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies

Might radiation therapy in addition to chemotherapy improve overall survival of patients with non-oligometastatic Stage IV non-small cell lung cancer?: Secondary analysis of two prospective studies
10    49    0
Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer’s perspective

Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer’s perspective
10    80    0
Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines

Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines
9    61    0
Molecular identification of an immunityand Ferroptosis-related gene signature in non-small cell lung Cancer

Molecular identification of an immunityand Ferroptosis-related gene signature in non-small cell lung Cancer
9    207    1
Inflammation‑scores as prognostic markers of overall survival in lung cancer: A register‑based study of 6,210 Danish lung cancer patients

Inflammation‑scores as prognostic markers of overall survival in lung cancer: A register‑based study of 6,210 Danish lung cancer patients
10    33    2
The role of EGFR mutation as a prognostic factor in survival after diagnosis of brain metastasis in non-small cell lung cancer: A systematic review and meta-analysis

The role of EGFR mutation as a prognostic factor in survival after diagnosis of brain metastasis in non-small cell lung cancer: A systematic review and meta-analysis
9    68    0
Overall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: Results of a prospective single-center study

Overall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: Results of a prospective single-center study
9    52    0
Lung cancer incidence differences in migrant men in Belgium, 2004–2013: Histology-specific analyses

Lung cancer incidence differences in migrant men in Belgium, 2004–2013: Histology-specific analyses
15    36    1
Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer

Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer
6    50    0
Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: A SEER cancer registry analysis

Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: A SEER cancer registry analysis
6    53    0
A systematic analysis of immune genes and overall survival in cancer patients

A systematic analysis of immune genes and overall survival in cancer patients
9    50    0
Relationship between WBRT total dose, intracranial tumor control, and overall survival in NSCLC patients with brain metastases - a single-center retrospective analysis

Relationship between WBRT total dose, intracranial tumor control, and overall survival in NSCLC patients with brain metastases - a single-center retrospective analysis
12    79    0
Real-world treatment and survival of patients with advanced non-small cell lung Cancer: A German retrospective data analysis

Real-world treatment and survival of patients with advanced non-small cell lung Cancer: A German retrospective data analysis
14    60    0
Postoperative radiotherapy is effective in improving survival of patients with stage pIII-N2 non-small-cell lung Cancer after pneumonectomy

Postoperative radiotherapy is effective in improving survival of patients with stage pIII-N2 non-small-cell lung Cancer after pneumonectomy
8    49    0
Postoperative chemoradiotherapy is superior to postoperative chemotherapy alone in squamous cell lung cancer patients with limited N2 lymph node metastasis

Postoperative chemoradiotherapy is superior to postoperative chemotherapy alone in squamous cell lung cancer patients with limited N2 lymph node metastasis
8    58    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.